Cipla’s generic Ventolin HFA secures USFDA approval
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The system is powered by BrainSense technology, which has received approval from USFDA
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
By cutting pain crises & boosting haemoglobin
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The conclave brought together over 1,000 delegates from across India and internationally
Move strengthens footprint in Western India and expands multi-specialty care network
The investment case for health technology in India is frequently overstated in one direction and understated in another
Subscribe To Our Newsletter & Stay Updated